<VariationArchive VariationID="555939" VariationName="NM_000153.4(GALC):c.1896_1900del (p.Thr633fs)" VariationType="Deletion" Accession="VCV000555939" Version="10" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-04-15" DateCreated="2018-08-05" MostRecentSubmission="2024-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="547384" VariationID="555939">
      <GeneList>
        <Gene Symbol="GALC" FullName="galactosylceramidase" GeneID="2581" HGNC_ID="HGNC:4115" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="87933014" stop="87993667" display_start="87933014" display_stop="87993667" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="88399357" stop="88460008" display_start="88399357" display_stop="88460008" Strand="-" />
          </Location>
          <OMIM>606890</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000153.4(GALC):c.1896_1900del (p.Thr633fs)</Name>
      <CanonicalSPDI>NC_000014.9:87939915:ACGTGA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q31.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="87939916" stop="87939920" display_start="87939916" display_stop="87939920" variantLength="5" positionVCF="87939915" referenceAlleleVCF="AACGTG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="88406260" stop="88406264" display_start="88406260" display_stop="88406264" variantLength="5" positionVCF="88406259" referenceAlleleVCF="AACGTG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>T610fs</ProteinChange>
      <ProteinChange>T607fs</ProteinChange>
      <ProteinChange>T633fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.88406261_88406265del" Assembly="GRCh37">
            <Expression>NC_000014.8:g.88406261_88406265del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.87939917_87939921del" Assembly="GRCh38">
            <Expression>NC_000014.9:g.87939917_87939921del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011853.3" sequenceAccession="NG_011853" sequenceVersion="3" change="g.58644_58648del">
            <Expression>NG_011853.3:g.58644_58648del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000153.4" sequenceAccession="NM_000153" sequenceVersion="4" change="c.1896_1900del" MANESelect="true">
            <Expression>NM_000153.4:c.1896_1900del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000144.2" sequenceAccession="NP_000144" sequenceVersion="2" change="p.Thr633fs">
            <Expression>NP_000144.2:p.Thr633fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001201401.2" sequenceAccession="NM_001201401" sequenceVersion="2" change="c.1827_1831del">
            <Expression>NM_001201401.2:c.1827_1831del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001188330.1" sequenceAccession="NP_001188330" sequenceVersion="1" change="p.Thr610fs">
            <Expression>NP_001188330.1:p.Thr610fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001201402.2" sequenceAccession="NM_001201402" sequenceVersion="2" change="c.1818_1822del">
            <Expression>NM_001201402.2:c.1818_1822del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001188331.1" sequenceAccession="NP_001188331" sequenceVersion="1" change="p.Thr607fs">
            <Expression>NP_001188331.1:p.Thr607fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000153.3" sequenceAccession="NM_000153" sequenceVersion="3" change="c.1896_1900delCACGT">
            <Expression>NM_000153.3:c.1896_1900delCACGT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000153.4" sequenceAccession="NM_000153" sequenceVersion="4" change="c.1896_1900delCACGT" MANESelect="true">
            <Expression>NM_000153.4:c.1896_1900delCACGT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="749708827" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000153.4(GALC):c.1896_1900del (p.Thr633fs) AND Galactosylceramide beta-galactosidase deficiency" Accession="RCV000671860" Version="7">
        <ClassifiedConditionList TraitSetID="1051">
          <ClassifiedCondition DB="MedGen" ID="C0023521">Galactosylceramide beta-galactosidase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-02-04" SubmissionCount="4">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000153.4(GALC):c.1896_1900del (p.Thr633fs) AND not provided" Accession="RCV001563136" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-07-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-02-04" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2018-08-05" MostRecentSubmission="2024-04-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16607461</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21824559</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22704718</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24252386</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26865610</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27638593</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27679535</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27780934</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9272171</ID>
        </Citation>
        <DescriptionHistory Dated="2020-09-14">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1051" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2446" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Leukodystrophy, Globoid Cell</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Krabbe leukodystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Globoid cell leukoencephalopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Galactosylceramide beta-galactosidase deficiency</ElementValue>
                <XRef ID="Krabbe+leukodystrophy/4044" DB="Genetic Alliance" />
                <XRef ID="192782005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Galactocerebrosidase deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GCL</ElementValue>
                <XRef Type="MIM" ID="245200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GLD</ElementValue>
                <XRef Type="MIM" ID="245200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Krabbe disease comprises a spectrum ranging from infantile-onset disease (i.e., onset of extreme irritability, spasticity, and developmental delay before age 12 months) to later-onset disease (i.e., onset of manifestations after age 12 months and as late as the seventh decade). Although historically 85%-90% of symptomatic individuals with Krabbe disease diagnosed by enzyme activity alone have infantile-onset Krabbe disease and 10%-15% have later-onset Krabbe disease, the experience with newborn screening (NBS) suggests that the proportion of individuals with possible later-onset Krabbe disease is higher than previously thought. Infantile-onset Krabbe disease is characterized by normal development in the first few months followed by rapid severe neurologic deterioration; the average age of death is 24 months (range 8 months to 9 years). Later-onset Krabbe disease is much more variable in its presentation and disease course.</Attribute>
                <XRef ID="NBK1238" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6844" />
                <XRef ID="6844" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301416</ID>
                <ID Source="BookShelf">NBK1238</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AAP, 2021">
                <URL>https://publications.aap.org/pediatrics/article/148/3/e2021053126/181065/Leukodystrophies-in-Children-Diagnosis-Care-and</URL>
                <CitationText>Leukodystrophies in Children: Diagnosis, Care, and Treatment, Pediatrics (2021) 148 (3): e2021053126.</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Krabbe-Infantile.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased galactocerebrosidase, elevated psychosine, Krabbe Disease (infantile form), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Krabbe-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Krabbe disease: galactocerebrosidase deficiency, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Krabbe-Later-Onset.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased galactocerebrosidase, mildly elevated psychosine, Krabbe Disease (late-onset form), 2022</CitationText>
              </Citation>
              <XRef ID="487" DB="Orphanet" />
              <XRef ID="C0023521" DB="MedGen" />
              <XRef ID="MONDO:0009499" DB="MONDO" />
              <XRef Type="MIM" ID="245200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1547193" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="22923|OMIM:245200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000796890" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21824559</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22704718</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27638593</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="14" alternateAllele="A" referenceAllele="AACGTG" start="88406259" stop="88406264" variantLength="6" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000153.3:c.1896_1900del5</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="245200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2827828" SubmissionDate="2020-09-09" DateLastUpdated="2020-09-14" DateCreated="2020-09-14">
        <ClinVarSubmissionID localKey="NM_000153.3:c.1896_1900delCACGT|MedGen:C0023521" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001432099" DateUpdated="2020-09-14" DateCreated="2020-09-14" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-08-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21824559</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27638593</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22704718</ID>
          </Citation>
          <Comment>Variant summary: GALC c.1896_1900delCACGT (p.Thr633AsnfsX3) results in a premature termination codon, predicted to cause a truncation of the encoded protein. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4e-06 in 248814 control chromosomes. c.1896_1900delCACGT has been reported in the literature in individuals affected with Krabbe Disease (Duffner_2011, Tanner_2012). These data indicate that the variant may be associated with disease. At least one publication reported experimental evidence evaluating an impact on protein function, and demonstrated almost complete loss of activity for the truncated protein (Saavedra-Matiz_2016). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000153.3:c.1896_1900delCACGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Galactosylceramide beta-galactosidase deficiency</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0023521" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8118025</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3505700" SubmissionDate="2021-08-13" DateLastUpdated="2021-08-14" DateCreated="2021-08-14">
        <ClinVarSubmissionID localKey="GDXSV:29671" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001786024" DateUpdated="2021-08-14" DateCreated="2021-08-14" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant in the C-terminus predicted to result in protein truncation, as the last 53 amino acids are lost and replaced with 2 incorrect amino acids (Stenson et al., 2014; other references); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 22704718, 27638593, 21824559)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALC" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:727831</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000153.3:c.1896_1900delCACGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_22_20210812085049</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4255144" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4812584|MedGen:C0023521" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002233062" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9272171</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16607461</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24252386</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26865610</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27679535</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27780934</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27638593</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21824559</ID>
          </Citation>
          <Comment>This variant disrupts a region of the GALC protein in which other variant(s) (p.Leu634Ser) have been determined to be pathogenic (PMID: 9272171, 16607461, 24252386, 26865610, 27679535, 27780934). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this premature translational stop signal affects GALC function (PMID: 27638593). This sequence change creates a premature translational stop signal (p.Thr633Asnfs*3) in the GALC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 53 amino acid(s) of the GALC protein. This variant is present in population databases (rs749708827, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with Krabbe disease (PMID: 21824559). This variant is also known as c.1848_1852del. ClinVar contains an entry for this variant (Variation ID: 555939). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000014.8:g.88406260_88406264del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023521" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4897192" SubmissionDate="2024-04-12" DateLastUpdated="2024-04-15" DateCreated="2022-04-27">
        <ClinVarSubmissionID localKey="rmh/unit_1/hg38_NM_000153_4_GALC_c_1896_1900delCACGT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002503805" DateUpdated="2024-04-15" DateCreated="2022-04-27" Type="SCV" Version="2" SubmitterName="Molecular Genetics, Royal Melbourne Hospital" OrgID="508231" OrganizationCategory="laboratory" OrgAbbreviation="RMH" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21824559</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22704718</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27638593</ID>
          </Citation>
          <Comment>This sequence change in GALC is a frameshift variant that may cause a premature stop codon, p.(Thr633Asnfs*3), that is predicted to escape nonsense mediated decay and remove &lt;10% of the protein, however it is a truncation of a functionally important region in a gene where loss-of-function is an established disease mechanism (PMID: 27638593). This variant is present in a single individual in gnomAD v2.1 (1/112,760 alleles) in the European (non-Finnish) population. This variant has been detected in at least two individuals with Krabbe disease and deficient GALC activity. Both were compound heterozygous for the variant and a pathogenic variant and one of those were confirmed in trans by parental testing (PMID: 21824559, 22704718). RMH ACMG Guidelines v1.5.1, this variant is classified as LIKELY PATHOGENIC. Following criteria are met: PVS1_Strong, PM3, PM2_Supporting, PP4.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_3865</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000153.4:c.1896_1900delCACGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0009499" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_12</SubmissionName>
          <SubmissionName>submission_41</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4255144" TraitType="Disease" MappingType="XRef" MappingValue="C0023521" MappingRef="MedGen">
        <MedGen CUI="C0023521" Name="Galactosylceramide beta-galactosidase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3505700" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4897192" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0009499" MappingRef="MONDO">
        <MedGen CUI="C0023521" Name="Galactosylceramide beta-galactosidase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2827828" TraitType="Disease" MappingType="Name" MappingValue="Galactosylceramide beta-galactosidase deficiency" MappingRef="Preferred">
        <MedGen CUI="C0023521" Name="Galactosylceramide beta-galactosidase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1547193" TraitType="Disease" MappingType="XRef" MappingValue="245200" MappingRef="OMIM">
        <MedGen CUI="C0023521" Name="Galactosylceramide beta-galactosidase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

